First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority Review
If the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.
Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results
Moderna's investigational vaccine against RSV in adults showed mean efficacy of 83% against the infection and is the only mRNA technology-based RSV shot.
Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection
The finding implies the potential for virus transmission after initial recovery from the infection, according to study authors.
